Pharmafile Logo
Pharmafocus logo
Advanced Search

ESMO

Showing 5 posts of 5 posts found.

astrazeneca_plaque

AstraZeneca’s Tagrisso beats standard of care in halting NSCLC

September 11, 2017
Research and Development, Sales and Marketing AstraZeneca, ESMO, NSCLC, Tagrisso, non-small cell cell cancer, pharma, pharmaceutical

AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in …

News
mr058666-web

Merck says its Erbitux in combination with Folfox improves outcomes in colorectal cancer

July 4, 2016
Research and Development, Sales and Marketing Cancer, China, ESMO, Merck, colorectal cancer, drug trial, research, study

Merck said late-stage trials for its Erbitux (cetuximab) in combination with Folfox significantly improved progression free survival in metastatic colorectal …

News
Roche image

Roche’s Perjeta sees ‘impressive’ survival rates

September 29, 2014
Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid

Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …

News
european_flag

Europe warned over cancer research risk

July 27, 2014
Medical Communications, Research and Development, Sales and Marketing ESMO, EU, Macmillan, data

A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …

News

Pharma unprepared for personalised oncology

November 29, 2010
Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine

The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025